Related Experiment Videos
Clonal analysis in glioblastoma with epithelial differentiation
1Institute for Neuropathology, Charité Humboldt University, Berlin, Germany.
Brain Pathology (Zurich, Switzerland)
|January 6, 2001
Summary
Molecular analysis of TP53 gene mutations in glioblastomas (GBM) with epithelial differentiation confirmed a common clonal origin in two of five cases. This finding helps differentiate these rare tumors from collision neoplasms.
Area of Science:
- Oncology
- Molecular Pathology
- Cancer Genetics
Background:
- Glioblastomas (GBM) can exhibit epithelial differentiation, mimicking metastatic carcinoma.
- This morphological heterogeneity poses diagnostic challenges, raising concerns of collision tumors.
- Molecular analysis is crucial for determining tumor origin and clonality.
Purpose of the Study:
- To investigate the clonal origin of glioblastomas with epithelial differentiation.
- To analyze TP53 gene mutations in these rare GBM variants.
- To differentiate true GBM with epithelial differentiation from collision tumors.
Main Methods:
- Microdissection of five GBM samples with epithelial differentiation.
- Analysis of TP53 gene mutations in exons 5-8 using SSCP and direct sequencing.
- Comparative mutation analysis in areas of astrocytic and epithelial differentiation.
Main Results:
- TP53 mutations were identified in two of five GBM cases.
- A G-->T transversion in codon 176 was found in a GBM initially misdiagnosed as metastasis.
- A C-->T transition in codon 211 was detected in another GBM with epithelial differentiation.
- Identical mutations were present in both astrocytic and epithelial areas within the same tumor, confirming clonality.
Conclusions:
- Molecular analysis of TP53 mutations supports a clonal origin for GBMs with epithelial differentiation.
- These findings exclude the possibility of collision tumors in the analyzed cases.
- Morphologically diverse GBMs can arise from a single neoplastic clone.